ABSOLUTE LYMPHOCYTE COUNT RECOVERY AS PROGNOSTIC MARKER OF SURVIVAL IN PEDIATRIC PRECURSOR B ACUTE LYMPHOBLASTIC LEUKEMIA

被引:0
|
作者
Asim, Muhammad [1 ]
Naithani, Rahul [1 ]
Abdelhaleem, Mohamed [1 ]
Punnett, Angela [1 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1029 / 1029
页数:1
相关论文
共 50 条
  • [1] PROGNOSTIC SIGNIFICANCE OF ABSOLUTE LYMPHOCYTE COUNT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Sidhom, Iman
    Soliman, Sonya
    Khalil, Sahar
    Mokhles, Abeer
    Osman, Diana
    Salem, Sherine
    Shaaban, Khaled
    El-Anwar, Wafaa
    Sabry, Mohamed
    Hussein, Hany
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1030 - 1031
  • [2] IS IT REALLY USEFUL AS A PROGNOSTIC FACTOR THE ABSOLUTE LYMPHOCYTE COUNT AT THE END OF INDUCTION THERAPY IN IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA?
    Lopez-Almaraz, R.
    Udaondo, J.
    Rubio-Rojas, R.
    Zubiaur, O.
    Garcia-Ariza, M.
    Echebarria-Barona, A.
    Adan-Pedroso, R. M.
    Astigarraga, I.
    Navajas, A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S254 - S255
  • [3] The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia
    Cheng, Yuping
    Luo, Zebin
    Yang, Shilong
    Jia, Ming
    Zhao, Haizhao
    Xu, Weiqun
    Tang, Yongmin
    LEUKEMIA RESEARCH, 2015, 39 (02) : 144 - 150
  • [4] Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia
    Farkas, Tamas
    Muller, Judit
    Erdelyi, Daniel J.
    Csoka, Monika
    Kovacs, Gabor T.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 889 - 897
  • [5] THE TETRASPANIN CD9 IS A PROGNOSTIC MARKER FOR PREDICTING SURVIVAL OUTCOMES OF PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Leung, K. T.
    Chan, K. Y. Y.
    Zhang, C.
    Leung, A. W. K.
    Cheng, F. W. T.
    Yu, J. W. S.
    Leung, T. F.
    Li, K.
    Li, C. K.
    HAEMATOLOGICA, 2017, 102 : 33 - 33
  • [6] Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia
    Satoshi Hirase
    Daiichiro Hasegawa
    Hironobu Takahashi
    Kensuke Moriwaki
    Atsuro Saito
    Aiko Kozaki
    Toshiaki Ishida
    Tomoko Yanai
    Keiichiro Kawasaki
    Nobuyuki Yamamoto
    Ikuko Kubokawa
    Takeshi Mori
    Akira Hayakawa
    Noriyuki Nishimura
    Hisahide Nishio
    Kazumoto Iijima
    Yoshiyuki Kosaka
    International Journal of Hematology, 2015, 102 : 594 - 601
  • [7] Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia
    Hirase, Satoshi
    Hasegawa, Daiichiro
    Takahashi, Hironobu
    Moriwaki, Kensuke
    Saito, Atsuro
    Kozaki, Aiko
    Ishida, Toshiaki
    Yanai, Tomoko
    Kawasaki, Keiichiro
    Yamamoto, Nobuyuki
    Kubokawa, Ikuko
    Mori, Takeshi
    Hayakawa, Akira
    Nishimura, Noriyuki
    Nishio, Hisahide
    Iijima, Kazumoto
    Kosaka, Yoshiyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (05) : 594 - 601
  • [8] Prognostic Significance of Absolute Lymphocytic Count Recovery in Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute
    Shibl, A.
    Sayed, H.
    Gaber, N.
    Alieldin, N.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S158 - S159
  • [9] Peripheral Blood Lymphocyte Recovery and Overall Survival in Pediatric Acute Lymphoblastic Leukemia
    Hatzipantelis, Emmanuil
    Pana, Zoe Dorothea
    Vlachou, Maria
    Papageorgiou, Theodotis
    Tragiannidis, Athanassios
    Athanassiadou, Fani
    PEDIATRIC BLOOD & CANCER, 2014, 61 (01) : 181 - 183
  • [10] ABSOLUTE LYMPHOCYTE COUNT RECORVERY AT THE END OF INDUCTION PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA IN GUATEMALA
    Fernandez, Karen
    Bostwick, Ann
    Giron, Veronica
    Garrido, Claudia
    Castellanos, Mauricio
    Wang, Huaping
    Valverde, Patricia
    Antillon-Klussmann, Federico
    de Alarcon, Pedro
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S47 - S47